Pregabalin Capsule
Product Images NDC 70518-4579

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 70518-4579). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Pregabalin 75mg 70518 4579 00)

This text is an evaluation of a Pregabalin Capsule C-V, 75 mg, with a quantity of 90 capsules. It provides information on the NDC number, expiration date, manufacturer details, and dosage instructions. The text also includes cautionary information regarding the transfer of the drug and storage conditions to keep the medication out of reach of children. The capsule is described as white with the imprint "1380:75" and it is directed for use by prescription only.*

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 01)

This is a formula used to calculate Creatinine Clearance Rate (CLRr) in adults. It takes into account the age, weight, gender, and serum creatinine level of the individual. For female patients, an additional factor of 0.85 is used in the calculation. The formula can help evaluate kidney function in patients.*

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 02)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 03)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 04)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 05)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 06)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 07)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 08)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 09)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 10)

This text provides data on Responder Rate (%) for different treatments administered in a study. The study includes placebo, 2.5 mg/kg/day treatment, and 10 mg/kg/day treatment. The Responder Rates given are 40.6%, 29.1%, and 22.6% respectively. It also includes the sample sizes for each treatment group, with the placebo group having 93 participants, the 2.5 mg/kg/day group having 103 participants, and the 10 mg/kg/day group having 9 participants.*

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 12)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 13)

FDA Label Image

Image (C3bcdf74 0ed9 439b 8f44 3f07e5c04e46 14)

FDA Label Image

Image (Figure 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.